AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36106379 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjunctive perampanel (≤8mg/day)
Number of subjects: 0
Study 33126867 — intervention group
Group type: EXPERIMENTAL
Intervention: HA-SIB-WBRT (Hippocampal Avoidance with Simultaneous Integrated Boost Whole Brain Radiotherapy)
Number of subjects: 100
Study 33126867 — intervention group
Group type: COMPARATOR
Intervention: HA-WBRT (Hippocampal Avoidance Whole Brain Radiotherapy)
Number of subjects: 100
Study 34971660 — intervention group
Group type: EXPERIMENTAL
Intervention: Anatomic stratification based on T and N category (TNM-8)
Number of subjects: 9468
Study 34971660 — intervention group
Group type: EXPERIMENTAL
Intervention: Prognostic stratification with pre-treatment EBV DNA ≥4000 copies/mL
Number of subjects: 9468
Study 34971660 — intervention group
Group type: EXPERIMENTAL
Intervention: Anatomic stratification (c-index)
Number of subjects: 9468
Study 34971660 — intervention group
Group type: EXPERIMENTAL
Intervention: Prognostic stratification (c-index)
Number of subjects: 9468
Study 34971660 — intervention group
Group type: COMPARATOR
Intervention: Existing TNM-8 stage groups (c-index)
Number of subjects: 9468
Study 34971660 — intervention group
Group type: COMPARATOR
Intervention: Validation cohort NCT01245959
Number of subjects: 9468
Study 34971660 — intervention group
Group type: COMPARATOR
Intervention: Validation cohort NCT01872962
Number of subjects: 9468
Study 34971660 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-treatment EBV DNA detectable
Number of subjects: 9468
Study 32022887 — intervention group
Group type: EXPERIMENTAL
Intervention: Pasireotide, 900 μg, subcutaneously twice a day for 7 days
Number of subjects: 126
Study 32022887 — intervention group
Group type: COMPARATOR
Intervention: Hydrocortisone, 100 mg, intravenously 3 times a day for 3 days
Number of subjects: 126
Study 32022887 — intervention group
Group type: EXPERIMENTAL
Intervention: Pasireotide (subgroup analysis)
Number of subjects: 126
Study 32022887 — intervention group
Group type: COMPARATOR
Intervention: Hydrocortisone (subgroup analysis)
Number of subjects: 126
Study 34471156 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep convolutional neural network binary classification model
Number of subjects: 84
Study 32265834 — intervention group
Group type: EXPERIMENTAL
Intervention: medroxyprogesterone acetate +hMG
Number of subjects: 450
Study 32265834 — intervention group
Group type: EXPERIMENTAL
Intervention: dydrogesterone +hMG
Number of subjects: 450
Study 32265834 — intervention group
Group type: EXPERIMENTAL
Intervention: progesterone +hMG
Number of subjects: 450
Study 33443485 — intervention group
Group type: EXPERIMENTAL
Intervention: Using technology to access health information and services
Number of subjects: 1734
Study 33443485 — intervention group
Group type: COMPARATOR
Intervention: Not using technology to access health information and services
Number of subjects: 1734
Study 32404919 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-minute postural training program (G1)
Number of subjects: 40
Study 32404919 — intervention group
Group type: COMPARATOR
Intervention: 6-minute rest (G2)
Number of subjects: 40
Study 32981693 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand-Assisted Retroperitoneoscopic Donor Nephrectomy (HARP)
Number of subjects: 100
Study 32981693 — intervention group
Group type: COMPARATOR
Intervention: Open Anterior Approach Donor Nephrectomy (AA)
Number of subjects: 100
Study 33239943 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga stretching
Number of subjects: 10
Study 34417681 — intervention group
Group type: EXPERIMENTAL
Intervention: Spirituality-based program
Number of subjects: 60
Study 34417681 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 60
Study 34282693 — intervention group
Group type: EXPERIMENTAL
Intervention: Bacteraemia confirmed by blood culture
Number of subjects: 200
Study 34282693 — intervention group
Group type: EXPERIMENTAL
Intervention: Bacteraemia
Number of subjects: 200
Study 34282693 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic administration during resuscitation
Number of subjects: 200
Study 32525465 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol consumption
Number of subjects: 940
Study 32525465 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonadherence
Number of subjects: 940
Study 32525465 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol use
Number of subjects: 940
Study 32525465 — intervention group
Group type: EXPERIMENTAL
Intervention: Viral load <200 copies/mL
Number of subjects: 940
Study 35008040 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant supplementation (AS) with 1000 IU·d‐1 natural vitamin E and 1000 mg·d‐1 vitamin C
Number of subjects: 15
Study 35008040 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 32799362 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrolyzed marine collagen (Vinh Wellness Collagen, VWC)
Number of subjects: 100
Study 32799362 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 35660812 — intervention group
Group type: EXPERIMENTAL
Intervention: RVD plus ASCT
Number of subjects: 722
Study 35660812 — intervention group
Group type: COMPARATOR
Intervention: RVD alone
Number of subjects: 722
Study 32511981 — intervention group
Group type: EXPERIMENTAL
Intervention: Ripretinib 150 mg once daily
Number of subjects: 129
Study 32511981 — intervention group
Group type: COMPARATOR
Intervention: Placebo once daily
Number of subjects: 129
Study 32511981 — intervention group
Group type: EXPERIMENTAL
Intervention: Ripretinib
Number of subjects: 129
Study 32511981 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 129
Study 36261200 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracolumbar interfacial plane block (TLIP)
Number of subjects: 64
Study 34085467 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 138
Study 34085467 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupoint catgut embedding
Number of subjects: 138
Study 34085467 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination group (EA + acupoint catgut embedding)
Number of subjects: 138
Study 32512513 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 Hz rTMS
Number of subjects: 118
Study 32512513 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 Hz rTMS
Number of subjects: 118
Study 32512513 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 118
Study 35057686 — intervention group
Group type: EXPERIMENTAL
Intervention: Gain-framed messages
Number of subjects: 981
Study 35057686 — intervention group
Group type: EXPERIMENTAL
Intervention: Loss-framed messages
Number of subjects: 981
Study 35057686 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-framed group)
Number of subjects: 981
Study 34419090 — intervention group
Group type: EXPERIMENTAL
Intervention: Oropharyngeal administration of colostrum (0.4 ml every 3 hours for 10 days within the first 48 hours after birth)
Number of subjects: 252
Study 34419090 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 252
Study 34419090 — intervention group
Group type: EXPERIMENTAL
Intervention: Oropharyngeal administration of colostrum
Number of subjects: 252
Study 32696887 — intervention group
Group type: EXPERIMENTAL
Intervention: Anxiety disorder severity
Number of subjects: 54
Study 32696887 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher anxiety severity
Number of subjects: 54
Study 32696887 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher number of anxiety diagnoses
Number of subjects: 54
Study 34259920 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin suspension administered twice daily by gargling for 30 seconds and swallowing, starting on the first day of chemotherapy.
Number of subjects: 70
Study 34259920 — intervention group
Group type: COMPARATOR
Intervention: No azithromycin (control group).
Number of subjects: 70
Study 32266415 — intervention group
Group type: EXPERIMENTAL
Intervention: Over-the-top anterior cruciate ligament reconstruction technique that preserves the hamstring attachment
Number of subjects: 20
Study 32266415 — intervention group
Group type: COMPARATOR
Intervention: Classical reconstruction technique
Number of subjects: 20
Study 34265266 — intervention group
Group type: EXPERIMENTAL
Intervention: View of Relocation Scale (VRS)
Number of subjects: 202
Study 35225819 — intervention group
Group type: EXPERIMENTAL
Intervention: TeleClinical Care (TCC) with usual care
Number of subjects: 164
Study 35225819 — intervention group
Group type: COMPARATOR
Intervention: Control (usual care only)
Number of subjects: 164
Study 34711335 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel drug-coated devices (DCDs)
Number of subjects: 4316
Study 34711335 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 4316
Study 34711335 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4316
Study 35585281 — intervention group
Group type: EXPERIMENTAL
Intervention: Normobaric hypoxia (FiO2: 15%)
Number of subjects: 29
Study 33189641 — intervention group
Group type: EXPERIMENTAL
Intervention: Watchman FLX device
Number of subjects: 165
Study 34862643 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-Intensity Focused Ultrasound (LIFU) treatment, power output 2.5 W/cm2, frequency 1 MHz, treating time 20 minutes
Number of subjects: 16
Study 34862643 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-Intensity Focused Ultrasound (LIFU) treatment
Number of subjects: 16
Study 34862643 — intervention group
Group type: COMPARATOR
Intervention: Sham group (LIFU without energy output)
Number of subjects: 16
Study 33103776 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive muscle relaxation exercise (PMRE)
Number of subjects: 145
Study 33103776 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 145
Study 33305973 — intervention group
Group type: EXPERIMENTAL
Intervention: Nipple shield use (Pain Group)
Number of subjects: 59
Study 33305973 — intervention group
Group type: COMPARATOR
Intervention: Nipple shield use (Control Group)
Number of subjects: 59
Study 32329778 — intervention group
Group type: EXPERIMENTAL
Intervention: SPEEDI_Late
Number of subjects: 90
Study 32329778 — intervention group
Group type: EXPERIMENTAL
Intervention: SPEEDI_Early
Number of subjects: 90
Study 32329778 — intervention group
Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 90
Study 35661214 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasting-mimicking diet (FMD)
Number of subjects: 40
Study 35661214 — intervention group
Group type: COMPARATOR
Intervention: Mediterranean diet
Number of subjects: 40
Study 32394278 — intervention group
Group type: COMPARATOR
Intervention: SLCTlow (100 kVp)
Number of subjects: 25
Study 32394278 — intervention group
Group type: EXPERIMENTAL
Intervention: DLCTlow (120 kVp)
Number of subjects: 25
Study 32394278 — intervention group
Group type: EXPERIMENTAL
Intervention: DLCThigh (120 kVp)
Number of subjects: 25
Study 33632649 — intervention group
Group type: EXPERIMENTAL
Intervention: Provider mobile phone application plus patient educational tool
Number of subjects: 14
Study 33632649 — intervention group
Group type: COMPARATOR
Intervention: Control group for provider mobile phone application plus patient educational tool
Number of subjects: 14
Study 33632649 — intervention group
Group type: EXPERIMENTAL
Intervention: Provider mobile phone application only
Number of subjects: 14
Study 33632649 — intervention group
Group type: COMPARATOR
Intervention: Control group for provider mobile phone application only
Number of subjects: 14
Study 34322745 — intervention group
Group type: EXPERIMENTAL
Intervention: Prognostic nomogram for predicting overall survival (OS)
Number of subjects: 5585
Study 34322745 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram calibration plots
Number of subjects: 5585
Study 34796837 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate combined with prednisolone
Number of subjects: 347
Study 34796837 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate combined with anti-TNF (certolizumab-pegol)
Number of subjects: 347
Study 34796837 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate combined with CTLA-4Ig (abatacept)
Number of subjects: 347
Study 34796837 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate combined with anti-IL6 receptor (tocilizumab)
Number of subjects: 347
Study 34796837 — intervention group
Group type: COMPARATOR
Intervention: Baseline plasma chemokine levels
Number of subjects: 347
Study 34444805 — intervention group
Group type: EXPERIMENTAL
Intervention: FIT Game intervention (n = 881)
Number of subjects: 1859
Study 34444805 — intervention group
Group type: COMPARATOR
Intervention: Control condition (n = 978)
Number of subjects: 1859
Study 33068146 — intervention group
Group type: EXPERIMENTAL
Intervention: Allogeneic human umbilical cord blood-derived mesenchymal stem cells (hUCB-MSCs) combined with high tibial osteotomy (HTO)
Number of subjects: 93
Study 35549460 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic-Assisted Fluoroscopic-Guided (RAF)
Number of subjects: 71
Study 35549460 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound-Guided (US)
Number of subjects: 71
Study 33076805 — intervention group
Group type: EXPERIMENTAL
Intervention: CSP group (n = 30)
Number of subjects: 60
Study 33076805 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 30)
Number of subjects: 60
Study 32053133 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 months of FOLFOX or CAPOX chemotherapy
Number of subjects: 1254
Study 32053133 — intervention group
Group type: COMPARATOR
Intervention: 6 months of FOLFOX or CAPOX chemotherapy
Number of subjects: 1254
Study 32053133 — intervention group
Group type: EXPERIMENTAL
Intervention: FOLFOX chemotherapy (3 months)
Number of subjects: 1254
Study 32053133 — intervention group
Group type: EXPERIMENTAL
Intervention: CAPOX chemotherapy (3 months)
Number of subjects: 1254
Study 32053133 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 months of chemotherapy
Number of subjects: 1254
Study 35762428 — intervention group
Group type: EXPERIMENTAL
Intervention: Kindergarten mode treatment (test group)
Number of subjects: 30
Study 35762428 — intervention group
Group type: COMPARATOR
Intervention: Control group (treated alternately with adult patients)
Number of subjects: 30
Study 34581765 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (20 μg/d)
Number of subjects: 200
Study 34581765 — intervention group
Group type: EXPERIMENTAL
Intervention: High-protein (HP) yogurt (10 g protein/100 g)
Number of subjects: 200
Study 34581765 — intervention group
Group type: COMPARATOR
Intervention: Normal-protein (NP) yogurt (3.5 g protein/100 g)
Number of subjects: 200
Study 34581765 — intervention group
Group type: COMPARATOR
Intervention: Placebo (no vitamin D)
Number of subjects: 200
Study 35484327 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandibular advancement appliance (MAA)
Number of subjects: 16
Study 35484327 — intervention group
Group type: COMPARATOR
Intervention: Without MAA
Number of subjects: 16
Study 34990497 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (BoNT‐A)
Number of subjects: 100
Study 34990497 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral appliance (OA)
Number of subjects: 100
Study 34990497 — intervention group
Group type: COMPARATOR
Intervention: Saline solution (SS)
Number of subjects: 100
Study 34990497 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison between BoNT‐A and OA
Number of subjects: 100
Study 34990497 — intervention group
Group type: COMPARATOR
Intervention: Comparison between BoNT‐A/OA and SS
Number of subjects: 100
Study 32728058 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower eGFR
Number of subjects: 0
Study 34921497 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold exposure (cooling vest perfused at 14°C for 2 hours)
Number of subjects: 10
Study 34921497 — intervention group
Group type: COMPARATOR
Intervention: No cold exposure (control)
Number of subjects: 10
Study 32816787 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapist-led exercise
Number of subjects: 256
Study 32816787 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound-guided corticosteroid injection
Number of subjects: 256
Study 32816787 — intervention group
Group type: COMPARATOR
Intervention: Exercise leaflet
Number of subjects: 256
Study 32816787 — intervention group
Group type: COMPARATOR
Intervention: Unguided corticosteroid injection
Number of subjects: 256
Study 33356966 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 60
Study 33356966 — intervention group
Group type: COMPARATOR
Intervention: Remifentanil
Number of subjects: 60
Study 33356966 — intervention group
Group type: COMPARATOR
Intervention: Sufentanil
Number of subjects: 60
Study 35725264 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 900
Study 35725264 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 900
Study 35725264 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 900
Study 32687296 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroneurostimulation (ENS) of the cervical sympathetic ganglia combined with gymnastics of the oculomotor muscles and shoulder girdle (MG)
Number of subjects: 120
Study 32687296 — intervention group
Group type: COMPARATOR
Intervention: Muscle gymnastics (GoC)
Number of subjects: 120
Study 32687296 — intervention group
Group type: COMPARATOR
Intervention: Placebo ENS (CG)
Number of subjects: 120
Study 35854327 — intervention group
Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA) taken daily until birth
Number of subjects: 158
Study 35854327 — intervention group
Group type: COMPARATOR
Intervention: Metformin taken daily until birth
Number of subjects: 158
Study 34106218 — intervention group
Group type: EXPERIMENTAL
Intervention: Granuloma annulare (GA)
Number of subjects: 5137
Study 32552707 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjustment of IOL power for the second eye as 50% of the RE of the first eye
Number of subjects: 94
Study 32552707 — intervention group
Group type: COMPARATOR
Intervention: No modification of IOL power (Control group)
Number of subjects: 94
Study 33563569 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous positive air pressure with a steady pressure of 4 cm H2O
Number of subjects: 80
Study 33563569 — intervention group
Group type: COMPARATOR
Intervention: Continuous positive air pressure with ideal therapeutic pressure
Number of subjects: 80
Study 32483622 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium-dose D1 activation (combination of levodopa and a D2 antagonist)
Number of subjects: 4
Study 32483622 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4
Study 32483622 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose D1 activation
Number of subjects: 4
Study 32483622 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose D1 activation
Number of subjects: 4
Study 34643642 — intervention group
Group type: EXPERIMENTAL
Intervention: Omecamtiv mecarbil
Number of subjects: 2258
Study 34643642 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2258
Study 33663383 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational lecture on JNET classification for NEE group
Number of subjects: 17
Study 33663383 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational lecture on JNET classification for LEE group
Number of subjects: 17
Study 33663383 — intervention group
Group type: COMPARATOR
Intervention: HEE group (control)
Number of subjects: 17
Study 35192440 — intervention group
Group type: EXPERIMENTAL
Intervention: Client-centered occupational therapy
Number of subjects: 20
Study 35192440 — intervention group
Group type: COMPARATOR
Intervention: General occupational therapy
Number of subjects: 20
Study 33591929 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness training for military veterans
Number of subjects: 0
Study 33591929 — intervention group
Group type: EXPERIMENTAL
Intervention: Various psychological interventions (procedural, sensory, behavioral, cognitive, relaxation, hypnosis, mindfulness, emotional, patient-generated narratives)
Number of subjects: 0
Study 33591929 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological interventions alongside analgesics or anesthetics
Number of subjects: 0
Study 33591929 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological interventions for patients undergoing abdominal and general surgery
Number of subjects: 0
Study 32791393 — intervention group
Group type: EXPERIMENTAL
Intervention: Dermal staples
Number of subjects: 40
Study 32791393 — intervention group
Group type: COMPARATOR
Intervention: Intradermal sutures
Number of subjects: 40
Study 34764377 — intervention group
Group type: EXPERIMENTAL
Intervention: Pinch and blow method
Number of subjects: 50
Study 34764377 — intervention group
Group type: COMPARATOR
Intervention: No pinch method
Number of subjects: 50
Study 33248590 — intervention group
Group type: EXPERIMENTAL
Intervention: Chitosan oligosaccharides (COS) supplementation at 200 mg/kg
Number of subjects: 108
Study 33248590 — intervention group
Group type: COMPARATOR
Intervention: Basal diet under cycle heat stress (HS group)
Number of subjects: 108
Study 33248590 — intervention group
Group type: COMPARATOR
Intervention: Basal diet and raised under normal temperature (CON group)
Number of subjects: 108
Study 35510598 — intervention group
Group type: EXPERIMENTAL
Intervention: In-person instructions
Number of subjects: 100
Study 35510598 — intervention group
Group type: COMPARATOR
Intervention: Video instructions
Number of subjects: 100
Study 34911199 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep learning enhanced images
Number of subjects: 0
Study 34911199 — intervention group
Group type: COMPARATOR
Intervention: Degraded images
Number of subjects: 0
Study 33570841 — intervention group
Group type: EXPERIMENTAL
Intervention: QuizTime smartphone application learning platform
Number of subjects: 0
Study 33570841 — intervention group
Group type: COMPARATOR
Intervention: Traditional avenues of knowledge dissemination
Number of subjects: 0
Study 33082712 — intervention group
Group type: EXPERIMENTAL
Intervention: Bergamot essential oil
Number of subjects: 80
Study 33082712 — intervention group
Group type: EXPERIMENTAL
Intervention: Sweet orange essential oil
Number of subjects: 80
Study 33082712 — intervention group
Group type: EXPERIMENTAL
Intervention: Bergamot juice
Number of subjects: 80
Study 33082712 — intervention group
Group type: EXPERIMENTAL
Intervention: Sweet orange juice
Number of subjects: 80
Study 33082712 — intervention group
Group type: COMPARATOR
Intervention: Physiological saline
Number of subjects: 80
Study 33082712 — intervention group
Group type: COMPARATOR
Intervention: Positive drugs
Number of subjects: 80